News
Mediterranean diet provides symptom relief for patients with irritable bowel syndrome in pilot study
A pilot study from Michigan Medicine researchers found that the Mediterranean diet may provide symptom relief for people with ...
The open-label, phase 1 trial evaluated the effect that pre-existing or treatment-induced anti-Ad5 neutralizing antibodies have on PCRX-201 and its impact on dosing and redosing strategy.
"This new, additional Phase 1 MAD data further highlights DA-1726's potential to be a best-in-class obesity treatment, showing impressive weight loss results, particularly in terms of BMI ...
the first phase III trial of an oral GLP-1 drug to successfully reach completion, a press release notes. Taken as a once-daily pill, orforglipron, unlike oral semaglutide (Rybelsus; Novo Nordisk), ...
LITTLE ROCK (KATV) — Pulaski County is set to announce the completion of Phase 1 of the Southwest Trail this morning, government officials said in a release. The Southwest Trail is a planned 65 ...
That includes the district’s long-range facilities plan which is nearing the end of Phase 1 and now the district is beginning to plan for Phase 2. About three years ago, the district began ...
The U.S. Space Force has added Rocket Lab USA and Stoke Space to the National Security Space Launch, or NSSL, Phase 3 Lane 1 contract as part of the first on-ramp process for the launch services ...
A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem ...
President Donald Trump's envoy to the Middle East, Steve Witkoff, said Sunday that he would aim to negotiate an "extension" of Phase One of the Israel-Hamas hostage release and ceasefire deal when ...
Prolong recently completed enrollment for Part 3 of the Phase 1 trial, marking a key milestone for the program. The final Data Safety Monitoring Board (DSMB) review was also completed with no ...
WALTHAM, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced positive data from its ongoing Phase 1/2 clinical trial of VYD2311, Invivyd's novel monoclonal ...
The assets being acquired include a Phase 2 lung cancer and Phase1 prostate cancer program, in addition to the gaining direct ownership of the underlying IP related ... a $7.1 million financing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results